// App-Quantinova.ai

2801 : Risk Factors Associated with 30-Day Unplanned Readmissions for Adult Acute Lymphoblastic Leukemia (ALL)

Researchers

Presenter

  • Veronica A Guerra

Principal Investigators

  • Yan Yuanqing

  • Jorge M. Ramos Perez

  • Guillaume Richard-Carpentier

  • Ahmad S. Alotaibi

  • Hycienth O Ahaneku

  • Bachar Samra

  • Arrvind Raghunath

  • Nitin Jain

  • Nicholas J. Short

  • Farhad Ravandi

  • Gautam Borthakur

  • Alessandra Ferrajoli

  • Koji Sasaki

  • Steven M. Kornblau

  • Zeev E. Estrov

  • Jorge E. Cortes

  • Hagop M. Kantarjian

  • Guillermo Garcia-Manero

  • Elias Jabbour

  • Tapan M. Kadia

Medical Centers

  • Department of Leukemia, The University of Texas MD Anderson Cancer Center,...

  • Department of Bioinformatics, The University of Texas MD Anderson Cancer Center, Houston, TX

  • University of Texas Health Science Center, Department of Neurosurgery, Houston

  • Department of Bioinformatics, The University of Texas MD Anderson Cancer Center, Houston, TX

  • Department of Bioinformatics, The University of Texas MD Anderson Cancer Center, Houston, TX

  • The University of Texas MD Anderson Cancer Canter, Houston, TX

  • Georgia Cancer Center, Augusta University, Augusta, GA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved